GLP1R and heart failure: One approach may lie with development of a better understanding of the effect of brief treatment with a glucagon like peptide-1 receptor (GLP1R) agonist on mitophagy and mitochondrial biogenesis when administered after the MI and the potential role of mitochondrial quality control in mitigating adverse remodeling and the development of heart failure.